Search | OpenScholar

Search results

302 results found

Katherine Blakeslee

Person: 415 Main St.

Management

Silvana Bazua

Person: 415 Main St.

Postdoctoral Scientist

Rob Law, Ph.D.

Person:

Mei-Hua Hall, Ph.D.

Person: Director, Psychosis Neurobiology Laboratory, McLean Hospital, Associate Professor of Psychiatry, Harvard Medical School

Contact Us

Page

Peter Tsvetkov

Person: Associate Member Broad Institute of MIT and Harvard; Principal Investigator BIDMC

Genomic evolution of cancer models: perils and opportunities

Publication: Journal Article

Ben-David, U., R. Beroukhim, and T. R. Golub. 2019. “Genomic Evolution of Cancer Models: Perils and Opportunities”. Nat Rev Cancer 19: 97-109.

A dataset of images and morphological profiles of 30 000 small-molecule treatments using the Cell Painting assay

Publication: Journal Article

Bray, M. A., S. M. Gustafsdottir, M. H. Rohban, S. Singh, V. Ljosa, K. L. Sokolnicki, J. A. Bittker, et al. 2017. “A Dataset of Images and Morphological Profiles of 30 000 Small-Molecule Treatments Using the Cell Painting Assay”. Gigascience 6: 1-5.

WRN helicase is a synthetic lethal target in microsatellite unstable cancers

Publication: Journal Article

Chan, E. M., T. Shibue, J. M. McFarland, B. Gaeta, M. Ghandi, N. Dumont, A. Gonzalez, et al. 2019. “WRN Helicase Is a Synthetic Lethal Target in Microsatellite Unstable Cancers”. Nature 568: 551-56.

CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2

Publication: Journal Article

Chen, L., G. Alexe, N. V. Dharia, L. Ross, A. B. Iniguez, A. S. Conway, E. J. Wang, et al. 2018. “CRISPR-Cas9 Screen Reveals a MYCN-Amplified Neuroblastoma Dependency on EZH2”. J Clin Invest 128: 446-62.